Results 191 to 200 of about 1,473,215 (222)

Management of localized scleroderma

Seminars in Cutaneous Medicine and Surgery, 1998
Localized scleroderma denotes a spectrum of conditions characterized by circumscribed fibrotic areas involving different levels of the dermis, subcutis, and sometimes underlying soft tissue and bone. Although the clinical course of the disease is often benign, widespread lesions and disabling joint contractures may lead to significant complications ...
N, Hunzelmann, K, Scharffetter Kochanek, C, Hager, T, Krieg   +3 more
openaire   +2 more sources

Localized Scleroderma

Archives of Dermatology, 1966
A case of linear and morphea scleroderma is reported. Histochemical studies revealed an increase of positive PAS material, diastase resistant, in the areas of homogenized collagen. Chemical analysis suggests an increase in hexoses and hexosamines, probably bound to the collagen fibers.
openaire   +1 more source

Localized scleroderma: Imaging features

Pediatric Radiology, 1994
Localized scleroderma is distinct from the diffuse form of scleroderma and does not show Raynaud's phenomenon and visceral involvement. The imaging features in 23 patients ranging from 2 to 17 years of age (mean 11.1 years) were reviewed. Leg length discrepancy and muscle atrophy were the most common findings (five patients), with two patients also ...
P, Liu, Y, Uziel, S, Chuang, E, Silverman, B, Krafchik, R, Laxer   +5 more
openaire   +2 more sources

Borrelia burgdorferi and localized scleroderma

Clinics in Dermatology, 1994
L yme borreliosis is a multisystemic disorder caused by the spirochete Borrelia burgdorferi and transmitted by the Ixodes tick. The initial manifestations of the disease are the characteristic skin lesion, erythema migrans, and symptoms of general malaise (stage I).
TREVISAN, GIUSTO, D. H. E. REES, G. STINCO   +2 more
openaire   +4 more sources

Ultraviolet A1 phototherapy for the treatment of localized scleroderma

Journal of dermatology (Print), 2020
Ultraviolet (UV)A1 phototherapy is effective for T‐cell‐mediated skin diseases such as atopic dermatitis and mast cell‐mediated skin diseases such as mastocytoma. UVA1 phototherapy is also effective against the sclerotic lesions of systemic sclerosis and
T. Furuhashi, K. Torii, K. Ikumi, H. Kato, E. Nishida, A. Morita   +5 more
semanticscholar   +1 more source

An extended high‐frequency ultrasound protocol for assessing and quantifying of inflammation and fibrosis in localized scleroderma

Skin research and technology, 2019
Clinical characteristics of the lesions are used to identify activity and damage in localized scleroderma (LoS). For high‐frequency ultrasound (HF‐US), the features of active lesions were described.
I. Ranosz-Janicka, A. Lis-Święty, Alina Skrzypek-Salamon, L. Brzezińska-Wcisło   +3 more
semanticscholar   +1 more source

Abnormal expression of interleukin-6 is associated with epidermal alternations in localized scleroderma

Clinical Rheumatology, 2022
Xingyu Zhu, Liuyiqi Jiang, Qian Zhong, Xiangzhen Kong, Rui Zhang, Ling Zhu, Qingmei Liu, Wenyu Wu, Yimei Tan, Jiucun Wang, Jing Xia   +10 more
semanticscholar   +1 more source

Localized scleroderma

Clinics in Dermatology, 1994
I, Ghersetich, P, Teofoli, M, Benci, S, Innocenti, T, Lotti   +4 more
openaire   +2 more sources

Prevalence and Incidence of Localized Scleroderma: A Qualitative Systematic Review

Journal of Cutaneous Medicine and Surgery, 2022
Farhana Mahmood, Alexandra Nguyen, A. Muntyanu, Abdulhadi Jfri, C. McCuaig, G. Chédeville, M. Piram, E. Netchiporouk   +7 more
semanticscholar   +1 more source

Localized scleroderma/morphea

International Journal of Dermatology, 2002
Virendra N, Sehgal, Govind, Srivastava, Ashok K, Aggarwal, Pran N, Behl, Manisha, Choudhary, Promila, Bajaj   +5 more
openaire   +2 more sources